News
Holdings announces that Sarah Cannon Research Institute, SCRI, at Colorado Blood Cancer Institute, CBCI, in Denver, ...
Novocure (NVCR) announced that it will present additional results from the Phase 3 PANOVA-3 trial of its Tumor Treating Fields therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback